Comment on the FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973-981

Diabetes Care. 2016 Oct;39(10):e186-7. doi: 10.2337/dc16-1133.

¹ Laboratory of Human Nutrition and Atherogenesis, University Institute of Clinical Research, University of Montpellier, Montpellier, France louis.monnier@inserm.fr.
² Laboratory of Human Nutrition and Atherogenesis, University Institute of Clinical Research, University of Montpellier, Montpellier, France.
³ Diabetes Research Group, Swansea University, Swansea, Wales, U.K.

No abstract available

Publication types